Nasdaq
$3.95▲ 1.41%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $244.7MShares out 62.0M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
31- 10.15Regular26.10.15 22:48SC14D9F/AOther#●●●#●●●
AURORA CANNABIS INC
The Board of Directors of Aurora Cannabis has unanimously recommended that shareholders reject Curaleaf's revised hostile bid of $1.00 in cash and 0.4013 of a Curaleaf share per Aurora share, citing significant undervaluation. The company is actively exploring strategic alternatives to maximize shareholder value and advises shareholders to take no action and not tender their shares before the December 4, 2026 expiration date.…more
$3.95+1.41%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.14After-hours26.10.15 05:186-KKey event
AURORA CANNABIS INC
The Board of Directors of Aurora Cannabis has unanimously recommended that shareholders reject the revised hostile takeover bid from Curaleaf. The company stated that it is currently debt-free with a strong cash position and is actively exploring strategic alternatives to maximize shareholder value. The Curaleaf offer remains open until December 4, 2026, and the company advises shareholders to take no action at this time.…more
$3.95+1.41%vs prev closeView filingShare - 10.8Pre-market26.10.08 21:166-KKey event
AURORA CANNABIS INC
Aurora Cannabis has completed a major expansion of its 'Aurora Horizon' manufacturing facility in Leuna, Germany. The expansion has more than doubled the expected annual flower output and secured an expanded EU-GMP license, strengthening the company's supply chain and production capacity for European markets.…more
$3.95+1.41%vs prev closeView filingShare
30 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 5d agoRegular26.10.20 01:28#●●●
Curaleaf Criticizes Aurora Cannabis for Rejecting Acquisition Bid
Curaleaf has strongly criticized Aurora Cannabis for advising shareholders to reject its improved acquisition bid, alleging a breach of fiduciary duty. The company claims Aurora is obstructing a concrete offer while ignoring the significant premium provided in the proposal.…more
$3.95+1.41%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 6d agoPre-market26.10.19 20:20
●●●●●●●● ●●●●● ●●●●●●
Curaleaf has criticized the Aurora Cannabis board for repeatedly recommending that shareholders reject its enhanced acquisition proposal. Curaleaf claims the board is failing its fiduciary duty by obstructing a high-value offer in favor of undisclosed parties.…more
$3.95+1.41%vs prev closeShareBenzinga - 10.14Regular26.10.15 04:55
●●●●●●●● ●●●●● ●●●●●●
The Board of Directors of Aurora Cannabis has unanimously recommended that shareholders reject the hostile takeover bid from Curaleaf Holdings. The decision follows a review by a special committee of independent directors who concluded the offer undervalues the company.…more
$3.95+1.41%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report